| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2879316 | The Annals of Thoracic Surgery | 2008 | 5 Pages |
Abstract
The maze III procedure significantly improves QoL in patients with AF. The results are consistent during an observation time of 35 months. Based on QoL effects in a long-term perspective, maze surgery should be considered in symptomatic patients with AF refractory to pharmacologic treatment or catheter ablation.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Catharina MD, Anders MD, PhD, Carina RN, Göran MD, PhD,